Deadline reports that the Goodfellas director is enlisting the help of Johnson, Emily Blunt, and Leonardo DiCaprio to produce ...

A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need to lose weight.

Recently, the firm has been leaning into its scale-driven cost advantage to emphasize its value offerings amid a challenging consumption spending environment. We view this strategy as prudent.